Key Takeaways
- Current FDA Status: BPC-157, TB-500 (Blend) is not FDA-approved and is available for research purposes only.
- Compounding Legality: These peptides cannot be compounded by 503A or 503B pharmacies due to their Category 2 designation by the FDA.
- Enforcement Actions: The FDA has issued warning letters and there have been DOJ prosecutions related to the illegal sale of these peptides.
- Research Use Only: Legally, these peptides can only be used in research settings, not for human consumption.
- Patient Implications: Verify clinic legality and watch for red flags indicating non-compliance with regulations.
Current FDA Status
As of 2026, BPC-157 and TB-500 (Blend) are not approved by the U.S. Food and Drug Administration (FDA) for any medical use. These peptides are categorized under research-only substances, meaning they are legally available solely for scientific and laboratory research purposes. The FDA has not listed these peptides on its bulk drug substance list for compounding, categorizing them as Category 2 substances, which are not eligible for compounding due to insufficient safety and efficacy data (Federal Register Notice).
Compounding Status
According to FDA guidelines, peptides not listed in Category 1 of the bulk drug substance list cannot be compounded by either 503A or 503B pharmacies. BPC-157 and TB-500 (Blend) fall under Category 2, which indicates a lack of sufficient data to support their safety and efficacy for compounding. This restriction is part of the FDA's efforts to regulate and ensure the safety of compounded medications (FDA Compounding Guidelines).
Enforcement Actions
The FDA and the Department of Justice (DOJ) have taken significant enforcement actions against entities involved in the illegal sale and distribution of BPC-157 and TB-500 (Blend). In 2025, the FDA issued multiple warning letters to companies marketing these peptides as dietary supplements or unapproved drugs. Additionally, the DOJ prosecuted several cases where individuals were charged with selling these peptides for human use, resulting in fines and criminal charges.
Prescription vs. Over-the-Counter vs. Research Use
Legally, BPC-157 and TB-500 (Blend) can only be purchased for research use. This means they cannot be prescribed by healthcare providers or sold over-the-counter for human consumption. "Research use only" indicates that these peptides are intended for laboratory research and not for diagnosing, treating, or preventing any disease in humans or animals (FDA Research Use Guidelines).
State-Level Variations
While federal regulations are clear, some states may have additional restrictions or enforcement actions related to the sale and use of research peptides. It's essential for researchers and clinics to be aware of and comply with both federal and state regulations to avoid legal repercussions.
What "Off-Label" Actually Means
The term "off-label" refers to the use of an FDA-approved drug for an unapproved indication. Since BPC-157 and TB-500 (Blend) have never received FDA approval, prescribing these peptides is not off-label; it is prescribing an unapproved drug, which is not permissible under current FDA regulations.
What This Means for Patients
Patients considering peptide therapy should exercise caution and ensure they are working with clinics that comply with legal standards. Verify that the clinic is not offering unapproved peptides for therapeutic use and be wary of any provider claiming to sell these peptides for anything other than research purposes. Red flags include clinics that do not disclose the regulatory status of the peptides they offer or make unsubstantiated claims about their efficacy.
Legal Alternatives
For patients seeking peptide therapies with similar benefits, it may be worth exploring FDA-approved alternatives or those in advanced clinical trials. Peptides such as semaglutide have undergone rigorous testing and have clear regulatory pathways.
FAQ
Q1: Can I legally purchase BPC-157, TB-500 (Blend) for personal use?
A1: No, these peptides are only legally available for research purposes and cannot be purchased for personal use.
Q2: Are there any FDA-approved peptides for tissue repair?
A2: Yes, some peptides like semaglutide are FDA-approved for specific indications. Consult a healthcare provider for more information.
Q3: What should I do if a clinic offers BPC-157, TB-500 (Blend) for therapy?
A3: Verify the clinic's compliance with FDA regulations and consider reporting them if they are offering unapproved treatments.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment. Legal status can change and was last verified February 2026.
Find a Peptide Therapy Clinic Near You
Browse our directory of verified peptide therapy clinics across the United States. Compare providers, read reviews, and request a consultation.
PeptideClinicLocator.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.



